ROR1 and BMI-1 proteins as potential predictors of the effectiveness of hormone therapy in luminal breast cancer | Tarakanova | Siberian journal of oncology

Siberian journal of oncology
Sibirskij onkologičeskij žurnal

ISSN 1814-4861 (Print)
ISSN 2312-3168 (Online)

eng | рус

Preview

Siberian journal of oncology

Advanced search

Archives

Download this PDF file

For citations:

Tarakanova V.O., Krakhmal N.V., Patalyak S.V., Tarasov M.N., Babyshkina N.N., Vtorushin S.V. ROR1 and BMI-1 proteins as potential predictors of the effectiveness of hormone therapy in luminal breast cancer. Siberian journal of oncology. 2022;21(3):135-142. https://doi.org/10.21294/1814-4861-2022-21-3-135-142

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1814-4861 (Print)
ISSN 2312-3168 (Online)

Editor-in-Chief

Evgeny L. Choynzonov

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Notifications

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

V. O. Tarakanova
Cancer Research Institute, Тomsk National Research Medical Center, Russian Academy of Sciences; Siberian State Medical University of the Ministry of Health of Russia
Russian Federation

Valeriia O. Tarakanova, MD, Postgraduate at Department of Cancer Research Institute; Assistant at the Oncology Department

5, Kooperativny St., 634009, Tomsk; 2, Moskovsky Trakt, 634050, Tomsk

N. V. Krakhmal
Cancer Research Institute, Тomsk National Research Medical Center, Russian Academy of Sciences; Siberian State Medical University of the Ministry of Health of Russia
Russian Federation

Nadezhda V. Krakhmal, MD, PhD, Associate Professor, Senior Researcher, Department of General and Molecular Pathology; Associate Professor

5, Kooperativny St., 634009, Tomsk; 2, Moskovsky Trakt, 634050, Tomsk

S. V. Patalyak
Cancer Research Institute, Тomsk National Research Medical Center, Russian Academy of Sciences; Siberian State Medical University of the Ministry of Health of Russia
Russian Federation

Stanislav V. Patalyak, MD, PhD, Head of the Department of Day hospital, Russian Academy of Sciences; Assistant at the Oncology Department

5, Kooperativny St., 634009, Tomsk; 2, Moskovsky Trakt, 634050, Tomsk

M. N. Tarasov
Siberian State Medical University of the Ministry of Health of Russia
Russian Federation

Mikhail N. Tarasov, MD, Resident of Oncology Department

2, Moskovsky Trakt, 634050, Tomsk

N. N. Babyshkina
Cancer Research Institute, Тomsk National Research Medical Center, Russian Academy of Sciences; Siberian State Medical University of the Ministry of Health of Russia
Russian Federation

Nataliya N. Babyshkina, MD, DSc, Senior Researcher, Laboratory of Molecular Oncology and Immunology, Russian Academy of Sciences; Associate Professor

5, Kooperativny St., 634009, Tomsk; 2, Moskovsky Trakt, 634050, Tomsk

S. V. Vtorushin
Cancer Research Institute, Тomsk National Research Medical Center, Russian Academy of Sciences; Siberian State Medical University of the Ministry of Health of Russia
Russian Federation

Sergey V. Vtorushin, MD, DSc, Head of the Department of General and Molecular Pathology; Professor at the Pathology Department

5, Kooperativny St., 634009, Tomsk; 2, Moskovsky Trakt, 634050, Tomsk